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Adrenal glands are zonated endocrine organs that are es-
sential in controlling body homeostasis. How zonation
is induced andmaintained and how renewal of the adrenal
cortex is ensured remain a mystery. Here we show that
capsular RSPO3 signals to the underlying steroidogenic
compartment to induce β-catenin signaling and imprint
glomerulosa cell fate. Deletion of RSPO3 leads to loss of
SHH signaling and impaired organ growth. Importantly,
Rspo3 function remains essential in adult life to ensure
replenishment of lost cells and maintain the properties
of the zona glomerulosa. Thus, the adrenal capsule acts
as a central signaling center that ensures replacement of
damaged cells and is required to maintain zonation
throughout life.
Supplemental material is available for this article.
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Themammalian adrenal gland is derived from the adrenal
primordium, a precursor of the adrenal cortex that be-
comes invaded by neural crest cells, which will later
form the adrenal medulla. By embryonic day 12.5 (E12.5)
in mice, the developing organ becomes surrounded by
condensing mesenchymal cells that ultimately form
the capsule (Bandiera et al. 2013). A second contribution
to the capsule is likely derived from adrenal progenitor
cells that have lost SF1 expression (Wood et al. 2013).
The permanent cortex is formed through recruitment of
capsular cells in a process that involves SHH signaling
(King et al. 2009). By E17.5, steroidogenic cells have
adopted specific expression profiles, with the outermost
cell layers (zona glomerulosa [ZG]) producing enzymes
that are required for mineralocorticoid production (e.g.,
CYP11B2), and deeper layers (zona fasciculata [ZF])
expressing genes involved in glucocorticoid synthesis
(Cyp11b1). In humans, but not rodents, a third layer
(zona reticularis) can be distinguished that produces an-
drogens and is located close to the medulla. Several lines
of evidence suggest that β-catenin plays an important
role in adrenal zonation and maintenance. Activation of
the β-catenin pathway is restricted to the ZG (Kim et al.
2008; Walczak et al. 2014), and ectopic expression leads
to the activation of ZG markers in ZF cells (Berthon
et al. 2010).Moreover, β-catenin seems to bind to and con-
trol the expression of At1r, a gene specifically expressed
within the ZG (Berthon et al. 2014). Finally, stochastic
deletion of β-catenin using a low-level expressing Sf1-
Cre line leads to progressive loss of the adrenal cortex in
adult life (Kim et al. 2008).
Results and Discussion
Recent lineage tracing studies have revealed that adrenal
maintenance likely involves cell conversion of ZG cells
into ZF cells (Freedman et al. 2013), with cells being dis-
placed in a centripetal fashion. In our search for signaling
molecules that may be involved in adrenal cell renewal
and zonation, we identified members of the R-spondin
gene family to be expressed from E12.5 onward within
mesenchymal cells surrounding the forming adrenal (Sup-
plemental Fig. S1). Expression of Rspo1 and Rspo3 was
maintained throughout development and well into adult-
hood (Fig. 1A; Supplemental Fig. S1A). R-spondins are
signaling molecules that bind to LGR receptors and posi-
tively modulate the β-catenin signaling pathway (de Lau
et al. 2014). As expected from previous studies, β-catenin
was highly expressed in the ZG (Fig. 1B). Moreover, im-
munofluorescence analysis revealed LGR5 to be enriched
within ZG cells (Fig. 1B), which is consistent with an ac-
tive RSPO/LGR5/β-catenin cascade.
The adrenal capsule consists of mesenchymal cells that
are positive for the SHH mediator GLI1 (King et al. 2009)
and COUPTFII (also known as NR2F2) (Wood et al. 2013)
and surrounded by a thin layer of mesothelial lining
expressing the Wilms tumor suppressor WT1 (Bandiera
et al. 2013). To determine whether Rspo1 and Rspo3 are
expressed in the same cell population, we performed
cell-sorting experiments on dissociated adult adrenals
from Wt1-GFP animals (Hosen et al. 2007). Quantitative
PCR (qPCR) analysis revealed the majority of Rspo1 ex-
pression to be within theWT1+ population (Supplemental
Fig. S1D), which is consistent with previously published
data showing a direct regulation of this gene by this
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transcription factor (Motamedi et al. 2014). In contrast,
Rspo3 appeared to be in a distinct cell population that
does not express high levels of WT1. RNA-Scope analysis
revealed Rspo3 to be expressed throughout the capsule
(Fig. 1C), reminiscent of the expression pattern of Gli1
(King et al. 2009) and NR2F2/COUPTFII (Wood et al.
2013). To test whether Rspo3-expressing cells may be
identical to the Gli1-positive population, we used a
Gli1-CreERT2 line in combination with a conditional
allele for Rspo3 (Rocha et al. 2015). Deletion was induced
at E14.5 by tamoxifen induction, and samples were col-
lected at E16.5 (Supplemental Fig. S1E). Strikingly, RNA
expression analysis showed an almost 70% reduction after
deletion, indicating that Gli1- and Rspo3-expressing cells
are largely identical (Supplemental Fig. S1F).
We next used genetic analysis to address whether
R-spondins may play a direct role in adrenal formation
and homeostasis. Deletion of Rspo1 was compatible
with survival (Chassot et al. 2008; Tomizuka et al. 2008)
and had no significant effect on adrenal development,
zonation, or tissue maintenance (Supplemental Fig. S2).
Rspo3-deficient embryos die early in development due
to defects in placenta formation (Kazanskaya et al.
2008). We therefore resorted to a tamoxifen-inducible ap-
proach (Fig. 1D) combining the Rspo3flox allele (Rocha
et al. 2015) with the ubiquitously expressed cCAG-
CreERT driver strain (Hayashi and McMahon 2002).
Induced deletion of Rspo3 at E11.5 resulted in smaller ad-
renals and thinning of the adrenal cortex at E16.5 (Fig. 1E).
Indeed, quantitation of SF1-positive cells revealed a 2.5-
fold decrease of the adrenal steroidogenic compartment
in the absence of Rspo3 (Fig. 1F,G).
The dramatic reduction of SF1+ cells inRspo3 knockout
animals indicated an important function for this gene
in the formation of the adult adrenal cortex. Previous stud-
ies have demonstrated a key role for SHH signaling in the
recruitment of capsular Gli1+ cells to the steroidogenic
lineage (Ching and Vilain 2009; King et al. 2009; Huang
et al. 2010), and Shh has been suggested to be regulated
by canonical β-catenin signaling in the adrenal system
(Drelon et al. 2015) and several other developmental sys-
tems (Iwatsuki et al. 2007; Ahn et al. 2010). To test wheth-
er this pathway is affected in Rspo3 mutants, we carried
out qPCR, immunohistochemistry, and in situ hybridiza-
tion (ISH) analysis on E16.5 tissues. Deletion resulted in a
near-complete loss of the β-catenin target Axin2 (Lustig
et al. 2002), thus indicating a requirement of Rspo3 for ca-
nonical signaling (Fig. 1H).Shhwasprominentlyexpressed
in steroidogenic cells juxtaposing the capsule of control
animals but becamealmost undetectable inRspo3mutant
animals (Fig. 1H,I). Consistentwith the loss of SHHsignal-
ing, expression of its direct target, Gli1, also disappeared
from capsular cells after Rspo3 deletion (Fig. 1I). Wnt4, a
gene that has been shown to be directly regulated by β-cat-
enin in the kidney (Park et al. 2012), was no longer ex-
pressed in the mutant cortex (Fig. 1I).
Taken together, these data suggest a double-paracrine
mechanism in adrenal cortex development, in which
RSPO3 is released from the capsule to induce β-catenin
signaling within juxtaposed steroidogenic cells, leading
to the activation of Shh. In turn, SHH signals back to cap-
sular cells, where it activates Gli1 and other downstream
targets to recruit cells to the steroidogenic lineage. Loss of
Rspo3 signaling leads to lack of cell recruitment and, as a
consequence, a severely reduced adrenal cortex.
Zonation of the adrenal cortex into ZG and ZF com-
mences at around E16.5 in mice and has been suggested
to depend on β-catenin signaling. Ubiquitous deletion of
Rspo3 at E11.5 results in heart failure (F Da Silva, AS
Rocha, J Ryler, C Basboga, H Morrison, KD Wagner, and
A Schedl, in prep.), thus prohibiting the analysis of later
time points. We therefore resorted to the capsular-ex-
pressed Gli1-CreERT2 strain and induced deletion at
E13.5, which resulted in a lack of Rspo3 expression at
E18.5 (Fig. 2A,B). Immunofluorescent analysis revealed
loss of the ZG-specificmarker DAB2 (Fig. 2C). In contrast,
expression of the ZF-specific markers AKR1B7 and
CYP11B1 persisted and now extended throughout the re-
maining cortex up to the capsule. BrdU labeling experi-
ments confirmed an almost complete loss of
proliferation in the adrenal cortex, whereas dividing cells
persisted in other tissues (Supplemental Fig. S3). NR2F2
expression persisted in the capsule (Fig. 2C), although
the number of cells also appeared to be somewhat reduced.
Figure 1. Rspo3 is expressed in the adrenal capsule and is required
for adrenal growth and the onset of zonation. (A) In situ hybridization
(ISH) analysis reveals Rspo1 and Rspo3 in the capsule surrounding
the adrenal cortex. (B) Immunostaining showing the LGR5 receptor
to be enriched in ZG cells that also show strong staining for β-catenin.
(C ) RNA-Scope analysis on adult adrenals. (D) Schematic outline
of the experimental strategy used. Rspo3 was deleted by injecting
tamoxifen into pregnant mothers at E11.5 and collecting embryos
at E16.5. (E) Macroscopic analysis (panels i,ii) and hematoxylin and
eosin (H&E) staining (panels iii,iv) demonstrate a dramatic reduction
of adrenal size in the absence of Rspo3 expression. (CAG) cCAG-
CreERT. (F ) Immunofluorescent analysis shows a reduction of adre-
nal cortex (SF1-positive cells; green) but not medullary (TH; light
blue) cells. (G) Quantification of SF1-positive cells confirms dramatic
loss of the steroidogenic compartment. nwt = 4; nko = 4; P = 8 × 10−4,
Student’s t-test. (H) Quantitative PCR (qPCR) analysis of RNA ex-
tracted from E16.5 adrenals. nwt = 3; nko = 4; Axin2, P = 9 × 10
−3; Shh,
P = 0.02. (I ) ISH analysis shows complete loss of Wnt4, Shh, and
Gli1 expression.
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To test whether continuous RSPO3 signaling was
required to maintain adrenal homeostasis, we induced
Cre recombination (cCAG-CreERT driven) in adult mice
(12 wk) and sacrificed animals at various time points after
induction (Fig. 3A). ISH confirmed near-complete loss
of Rspo3 expression in the adrenal capsule (Fig. 3B; Sup-
plemental Fig. S4B). Adrenal weight in Rspo3 mutants
progressively decreased over time and dropped to 50%
of that in control animals 6 wk after induction (Fig.
3C). Histological analyses confirmed a severely reduced
adrenal cortex, while the medulla appeared unaffected
(Fig. 3D). High-power views revealed loss of the typical
ZG organization in arches. Instead, the remaining cortical
cells showed the columnar arrangement reminiscent of
the ZF. To test whether mutant adrenals showed reduced
proliferation, we performed long-term BrdU tracing exper-
iments. In control animals, a large number of SF1/BrdU
double-positive cells were detected, indicating that they
underwent cell division during the labelling period (Fig.
3E). In contrast, BrdU-labeled cells were dramatically re-
duced afterRspo3 deletion, and SF1/BrdU double-positive
cells were almost absent.
To confirm the loss of ZG differentiation, we next
analyzed a range of molecular markers using ISH and
immunostaining. Wnt4, Shh, Gli1 (Fig. 4A), DAB2,
and CYP11B2 (Fig. 4B,C) were dramatically reduced in
mutant mice. Similar to development, the ZF marker
AKR1B7 now extended up to the capsule (Fig. 4B). qPCR
assays confirmed these findings with no alteration in ZF
markers and an almost complete loss of ZGmarker genes
(Fig. 4B).
To exclude secondary effects that might have been
caused by systemic deletion of Rspo3, we next performed
tissue-specific deletion experiments using the Gli1-Cre-
ERT2 strain (Supplemental Fig. S4A). qPCR analysis re-
vealed a reduction of Rspo3 expression to ∼30% of wild-
type levels, which is somewhat lower than what we
observed using the ubiquitously expressed cCAG-CreERT
line (Supplemental Fig. S4B). The less efficient deletion
is likely to be due to lower levels of expression from the
Gli1 promoter. Axin2 expression levels closely followed
those of Rspo3 (Supplemental Fig. S4A). Importantly,
Gli1-CreERT2-specific deletion also caused a reduction
of the adrenal cortex and the loss of ZG markers (Sup-
plemental Fig. S4C,D), indicating that, indeed, zonation
depends on capsular expression of Rspo3.
The striking loss of ZG markers could be caused by ei-
ther apoptosis of ZG cells, lack of cell renewal, or a contin-
uous requirement for RSPO3 signaling to specify ZG cells.
To distinguish between these alternatives, we analyzed
Figure 2. Deletion of RSPO3 interferes with the development of ad-
renal zonation. (A) Experimental setup using Rspo3fl/fl; Gli1-
CreERT2 animals. (B) ISH analysis at E18.5 showing the complete
loss of Rspo3 expression in mutant animals. (C ) Immunofluorescent
analysis demonstrates loss of the ZGmarker DAB2 and an expansion
of AKR1B7 up to the capsule. NR2F2-positive capsular cells aremain-
tained in mutant animals. (D) Cyp11b1 ISH, SF1 antibody staining,
and a digital overlay of the two data sets. The ZF marker Cyp11b1
also extends to the capsule in mutant animals (white arrows).
Figure 3. Continuous RSPO3 signaling is required for adrenal ho-
meostasis. (A) Experimental design. Twelve-week-old mice were in-
duced and analyzed at various time points. (B) Analysis at 4 wk
demonstrates a complete loss of capsular Rspo3 expression upon ta-
moxifen induction. (C ) Loss ofRspo3 leads to progressive loss of adre-
nal weight. 1 d, nwt = 6, nko = 6; 2 wk, nwt = 6, nko = 6; 4wk, nwt = 4, nko
= 5; 6 wk, nwt = 12, nko = 15. 2 wk, P = 1.5 × 10
−3; 4 wk, P = 2.6 × 10−3;
6 wk, P = 3.0 × 10−8, Student’s t-test. (D) Macroscopic and histologi-
cal examination (Azan staining) 6 wk after Rspo3 deletion reveals
smaller adrenal glands and the dramatic thinning and loss of the
ZG typical arrangement of cells in arches (black arrows). (E) BrdU
analysis (40 d) reveals a dramatic loss of proliferation after Rspo3
deletion. The only labeled cells in Rspo3 knockout animals (white
arrowheads) are nonsteroidogenic, as indicated by the absence of SF1.
Rspo3 in adrenal zonation and maintenance
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samples 1 d after completion of the tamoxifen deletion
protocol (Fig. 5), in which lack of cell renewal can be ex-
cluded. Knockout adrenals at this early time point showed
only a very mild reduction in size that did not reach stat-
istical significance (Fig. 3C). Caspase3 analysis identified
a number of apoptotic cells close to the medulla (Fig.
5B), which is consistent with the centripetal model of
cell renewal (Freedman et al. 2013). Deletion of Rspo3
did not increase apoptosis, thus excluding cell death as a
reason for the loss of ZG markers. Strikingly, molecular
analysis confirmed a near-complete loss of all ZGmarkers
analyzed (Shh, Wnt4, DAB2, and Cyp11b2) even at this
early time point after Rspo3 deletion (Fig. 5C). The ab-
sence of apoptosis in steroidogenic cells after Rspo3 dele-
tion and the expansion of ZF markers up to the capsule at
4 wk after deletion suggest that ZG cells convert to ZF
cells, a process that is also occurring under normal condi-
tions when steroidogenic cells move centripetally, thus
losing signals derived from the adrenal capsule (Freedman
et al. 2013).
Wnt4 has been demonstrated previously to be required
for the activation of Cyp11b2 expression (Heikkila et al.
2002), and we showed recently that this dependence also
persists in adult mice (C Drelon, A Berthon, I Sahut-Bar-
nola, M Mathieu, T Dumontet, S Rodriguez, M Batisse-
Lignier, H Tabbal, I Tauveron, AM Lefrançois-Martinez,
et al., in prep.). To test whether deletion of Wnt4 may
affect RSPO3-controlled signaling pathways and cell re-
newal, we analyzed Wnt4; Sf1-Cre knockout mice (Sup-
plemental Fig. S5A) that showed efficient depletion of
Wnt4 in adrenal glands (Supplemental Fig. S5C). Surpris-
ingly, mice survived into adulthood (>12 mo) with no
overt defects detectable. Adrenals in Wnt4 knockout
mice were only slightly smaller (Supplemental Fig. S5B),
demonstrating that this gene does not play a major role
in cell renewal. Molecular analysis revealed a significant
reduction of the ZG markers Axin2 and At1b but only a
mild reduction of Rspo3, Shh, and Gli1 expression that
did not reach statistical significance (Supplemental Fig.
S5C,D). Thus, Wnt4 appears to act as a local relay signal
that reinforces β-catenin activity in the ZG but does not
have a major influence on organ renewal.
A recent study suggested RSPO3 to bind to LGR5 and
induce noncanonical signaling in adrenal cortical cells.
This signaling appeared to inhibit aldosterone produc-
tion and cell renewal and induce apoptosis (Shaikh et al.
2015). These findings are in stark contrast to the data
presented in this study. We presume the discrepancy to
be caused by the in vitro setting of the previously reported
study, which does not take into account the complex
interactions of cells in an in vivo environment. Our data
clearly demonstrate a canonical role for Rspo3 signaling
within the adrenal cortex, where it induces well-estab-
lished direct downstream targets of β-catenin (Axin2
and Dab2) and maintains organ size in the adult orga-
nism. This role is consistent with the generally accepted
function of RSPO/LGR5 signaling in controlling the acti-
vation of the stem cell pool, and we can now add the adre-
nal cortex as an additional organ in which this pathway
is used.
Even more surprising than the involvement of RSPO3
in controlling organ renewal is its absolute requirement
for maintaining adrenal zonation. The rapid loss of
zonation markers after Rspo3 deletion in the adult de-
monstrates that it acts as an instructive signal to direct
Figure 4. Loss of Rspo3 abolishes adrenal zonation. ISH (A), immu-
nofluorescent (B), and immunohistochemical (C ) analyses reveal loss
of all ZG-specific markers analyzed. Note the persistence of pockets
of DAB2 expression (white arrowhead in B) that are likely associated
with incomplete deletion of Rspo3. (B) NR2F2 capsular cells appear
to be largely unaffected. (D) qPCR analysis confirms the dramatic re-
duction of expression of the β-catenin target Axin2 and a near loss of
ZG markers Cyp11B2 and Shh as well as the capsular marker Gli1.
nwt = 5; nko = 5. Rspo3, P = 8 × 10
−3; Axin2, P = 1 × 10−3; Cyp11B2,
P = 3 × 10−5; Shh, P = 2 × 10−3; Gli1, P = 5 × 10−3, Student’s t-test.
Figure 5. Rspo3 deletion leads to a rapid loss of ZG identity. (A) Ex-
perimental design. (B) Caspase staining revealed some apoptotic cells
close to the medulla, whereas the ZG was devoid even after deletion
of Rspo3. (C ) ISH and immunostaining demonstrated a rapid loss of
ZGmarker gene expression. Note the complete loss of DAB2 in a pro-
portion of subcapsular cells (white arrow) upon Rspo3 deletion. (D)
Model describing the central role of Rspo3 in establishing adrenal zo-
nation and ensuring cell renewal. Large red arrows symbolize the cen-
tripetal movement of cells during cell renewal. (Meso) Mesothelial
lining; (C) capsule.
Vidal et al.
1392 GENES & DEVELOPMENT
 Cold Spring Harbor Laboratory Press on April 11, 2017 - Published by genesdev.cshlp.orgDownloaded from 
steroidogenic cells toward the ZG phenotype. The adrenal
capsule is the ideal location to provide this stimulus.
Since R-spondins appear to be tightly bound to the extra-
cellular matrix (Kim et al. 2005), diffusion is limited, and
only several cell layers are instructed to express ZGmark-
ers. Activation of Wnt4 within the ZG cells is likely to
serve as a local reinforcement signal, as loss of Wnt4
also leads to a reduction of ZG markers (Supplemental
Fig. S5; Heikkila et al. 2002).
Apart from the adrenal cortex, hepatocytes also display
metabolic zonation along the liver lobule that is set up by
a gradient of canonical β-catenin signaling (Benhamouche
et al. 2006). We showed recently that, in a fashion similar
to the adrenal, liver zonation strictly depends on RSPO3
that is released from endothelial cells located in the cen-
tral vein (Rocha et al. 2015). Thus, our evidence suggests
that the liver and adrenal cortex have adopted the same
signaling system to establish organ-specific zonation de-
spite the fact that both organs are derived from distinct
embryological origins.
In conclusion, our data establish a genetic network in
which Rspo3 induces Wnt4 and Shh expression within
steroidogenic cells that are in close contact with the cap-
sule (Fig. 5D). Shh in turn signals back to recruit capsular
cells to form the adrenal cortex, at least during develop-
ment. The fact that Shh knockout mice show normal ad-
renal zonation (Huang et al. 2010) while Rspo3 deletion
affects ZG identity indicates that Rspo3 must also act
through additional, Shh-independent pathways. The dra-
matic thinning of the entire steroidogenic compartment
further supports the model of a ZG-driven adrenal cortex
renewal, a concept that has been put forward by Freedman
et al. (2013). Thus, our study identifies the adrenal capsule
as a crucial signaling center that, through the production
of RSPO3, not only ensures organ renewal but also pro-
vides an instructive signal that is continuously required
for proper zonation.
Materials and methods
Mouse work
All animal work was conducted according to national and international
guidelines and was approved by the local ethics committee (PEA-NCE/
2013-88). The Rspo1 (Chassot et al. 2008), Rspo3flox (Rocha et al. 2015),
Wt1-GFP (Hosen et al. 2007), Gli1-CreERT2 (Ahn and Joyner 2004),
cCAG-CreERT (Hayashi and McMahon 2002), Sf1-Cre (Bingham et al.
2006), andWnt4flox (Shan et al. 2009) lines have been described previously.
Cre activation during development was obtained by a single tamoxifen
administration (force feeding) of pregnant females carrying either E11.5,
E13.5, or E14.5 embryos. Cre activation in adult mice was obtained by
intraperitoneal injection of 12-wk-old mice with 1 mg of tamoxifen
(Sigma-Aldrich) dissolved in corn oil (Sigma-Aldrich) per 20 g of body
weight five times a week for 1 wk. With the exception of embryonic anal-
ysis, only male mice were used for the described experiments.
For proliferation assays, 1mg/mL BrdUwas added to drinking water, the
solution was changed every 2 d, and animals were sacrificed at the end of
4 wk of treatment.
Cell sorting
Adrenals from adult WT1GFP or control animals were collected and incu-
bated for 30 min in 1 mg/mL collagenase at 37°C, and the adrenal capsule
was separated from the rest of the adrenal using a binocular microscope.
After a further 30 min of incubation in trypsin at 37°C with occasional
pipetting up and down, the digestion was stopped by adding 100 µL of
FBS, and the cell suspension was filtered (40-µm filters), centrifuged
(2000 rpm for 3 min), and resuspended in 200 µL of PBS-EDTA-serum sol-
ution. Cells were analyzed with a FACS Aria II (BD).
Immunofluorescence and histological analysis
For immunofluorescence experiments, tissues were fixed overnight in
4% paraformaldehyde, progressively dehydrated, and paraffin-embedded.
Seven-micrometer-thick sections were rehydrated, boiled in a pressure
cooker for 2 min with antigen unmasking solution (Vector Laboratories),
and blocked in a PBS solution containing 10%normal donkey serum (Jack-
son Immunoresearch) and 3% BSA. All primary antibodies were applied
overnight at 4°C at the concentrations listed in the antibody table in the
Supplemental Material. Secondary antibodies were diluted 1:200 and ap-
plied at room temperature for 1 h. β-Catenin was detected using a bio-
tinylated secondary antibody followed by streptavidin-Cy3 detection
(Sigma-Aldrich).
For histological analysis, adrenal glands from embryos or adult mice
were fixed overnight in 4% paraformaldehyde, progressively dehydrated,
and embedded in paraffin. Seven-micrometer-thick sections were then
stained with hematoxylin and eosin according to standard procedures.
For CYP11B2 and caspase3 staining, sections were unmasked, incubated
for 30 min in H2O2 (30%), and blocked for 1 h in 5% PBS/BSA. Primary an-
tibody was left overnight at 4°C in 0.1% PBS/BSA, and polymer-Hrp rabbit
(Cell Signaling, 8114) was used as a secondary and incubated for 30 min at
room temperature. Revelation was performed with a Novared kit (Vector
Laboratories) for 4 min.
Azan staining
Histological sections at 5 µm were stained using the Azan trichrome kit
(Diapath) according to the manufacturer’s instructions.
RNA ISH
Tissues were fixed overnight in 4% paraformaldehyde, progressively
dehydrated, and paraffin-embedded. The Gli1 in situ probe was kindly
provided by M. Studer (Institute of Biology Valrose, Université de Nice-
Sophia Antipolis). Seven-micrometer-thick sections were hybridized
with Rspo1, Rspo3, Wnt4, and Shh as well as Gli1 probes according
to previously described protocols (Comai et al. 2010). RNA-Scope analysis
forRspo3was performed on adult sections according to themanufacturer’s
instructions.
Real-time PCR analysis
RNA was extracted from E16.5 or adult adrenal glands using TRIzol re-
agent (Invitrogen) following themanufacturer’s instructions. Reverse tran-
scription was performed using M-MLV reverse transcriptase (Invitrogen)
in combination with random primers. The cDNA obtained was then
used as template for qPCR analysis using the SYBR Green master kit
(Roche) and a LightCycler 1.5 (Roche). The expression levels were normal-
ized for Hprt. Primers (see the primer table in the Supplemental Material)
were designed on the Universal ProbeLibrary Web site (Roche).
Statistical analysis
Statistical significance was determined using two-tailed Student’s
t-test. Error bars in all figures represent the standard error of mean, and
P-values are indicated by asterisks as follows: P < 0.05 (∗), P < 0.01 (∗∗),
and P < 0.001 (∗∗∗).
For the developmental analysis (Fig. 1G), SF1-positive cells were count-
ed on every second section of four control and four knockout adrenals us-
ing Volocity 6.3 software. Statistical analysis was performed with the total
of nuclei obtained for each adrenal using a two-tailed Student’s t-test.
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